PMDA held the GCP inspection in Multi-Regional Clinical Trial (MRCT) Webinar for the Food and Drug Administration, the Republic of the Philippines (FDA Philippines) on December 6, 2022.
This webinar was designed for regulators of pharmaceutical products in the FDA Philippines and counted 32 participants.
In the webinar, a PMDA staff from Office of Non-clinical and Clinical Compliance gave a lecture and case study on GCP Inspections. A Q&A session was also held to enhance understanding of the topic.
The PMDA continuously makes efforts to strengthen collaboration with the FDA Philippines through projects such as the PMDA-ATC for Pharmaceuticals and Medical Devices Regulatory Affairs.
See attached program [53KB]
Back
Back
-
Regulations & Services of PMDAInformation about Approved Products in JapanSafety InformationAdvanced Efforts
-
Information for approved products in JapanSafety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnosticsInformation for approved products in JapanRegulatory science
-
Regulations and services of PMDAInformation for approved products in JapanProcedures in JapanAdvanced efforts
Back
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Reviews and Related ServicesRegulatory ProceduresPost-marketing Safety Measures
-
Reviews and Related ServicesPost-marketing Safety Measures
- Home
- Events and Symposia
- Report of the PMDA-ATC GCP inspection in MRCT Webinar 2022 for FDA Philippines
Events and Symposia